| |
Overall n = 80
|
No AF recurrence n = 59
|
AF recurrence n = 21
|
p-value
|
|---|
|
Demographics
|
|
Age, mean ± SD
|
58.6 ± 9.4
|
58.5 ± 11.5
|
58.6 ± 8.9
|
0.99
|
|
Male
|
60 (75)
|
42 (71.2)
|
18 (85.7)
|
0.2
|
|
Caucasian
|
76 (95)
|
54 (91.5)
|
21 (100)
|
0.64
|
|
Prior DC cardioversion
|
29 (36.3)
|
23 (39)
|
6 (28.6)
|
0.2
|
|
Comorbidities
|
|
Current/former smoker
|
20 (25)
|
16 (27.1)
|
4 (19)
|
0.29
|
|
Coronary artery disease
|
10 (12.5)
|
9 (15.3)
|
1 (4.8)
|
0.16
|
|
Peripheral arterial disease
|
1 (1.25)
|
0
|
1 (4.8)
|
0.12
|
|
Heart failure
|
8 (10)
|
7 (11.9)
|
1 (4.8)
|
0.28
|
|
Hypertension
|
38 (47.5)
|
27 (45.8)
|
11 (52.4)
|
0.92
|
|
Obstructive sleep apnea
|
18 (22.5)
|
11 (18.6)
|
7 (33.3)
|
0.33
|
|
Diabetes mellitus
|
3 (3.8)
|
3 (5.1)
|
0
|
0.27
|
|
Cerebrovascular disease
|
1 (1.25)
|
1 (1.7)
|
0
|
0.53
|
|
CHA2DS2-VASc score
|
|
0
|
22 (27.5)
|
16 (27.1)
|
6 (28.6)
|
0.79
|
|
1
|
32 (40)
|
21 (35.6)
|
11 (52.4)
|
0.45
|
|
2
|
16 (20)
|
13 (22)
|
3 (14.3)
|
0.30
|
|
≥ 3
|
10 (12.5)
|
7 (11.9)
|
3 (14.3)
|
0.61
|
|
Medications
|
|
Aspirin
|
17 (21.3)
|
11 (18.6)
|
6 (28.6)
|
0.57
|
|
Statin
|
29 (36.3)
|
1 (1.7)
|
2 (9.5)
|
0.15
|
|
Warfarin
|
9 (11.3)
|
7 (11.9)
|
2 (9.5)
|
0.62
|
|
Apixaban
|
12(15)
|
9 (15.3)
|
3 (14.3)
|
0.73
|
|
Rivaroxaban
|
35(43.8)
|
23 (39.0)
|
12 (57.1)
|
0.43
|
|
Dabigatran
|
4 (5)
|
3 (5.1)
|
1 (4.8)
|
0.85
|
|
Beta Blocker
|
55 (68.8)
|
40 (67.8)
|
15 (71.4)
|
0.52
|
|
Calcium channel blocker
|
22 (27.5)
|
18 (30.5)
|
4 (19)
|
0.18
|
|
Anti-Arrhythmic Therapy
|
45 (56.3)
|
32 (54.2)
|
13 (61.9)
|
0.33
|
|
Flecanaide
|
17 (21.3)
|
10 (16.9)
|
7 (33.3)
|
0.25
|
|
Propafenone
|
4 (5)
|
3 (5.1)
|
1 (4.8)
|
0.85
|
|
Sotalol
|
4 (5)
|
1 (1.7)
|
3 (14.3)
|
0.04
|
|
Amiodarone
|
4 (5)
|
4 (6.8)
|
0
|
0.20
|
|
Dronderone
|
14 (17.5)
|
11 (18.6)
|
3 (14.3)
|
0.48
|
|
ACE/ARB
|
22 (27.5)
|
19 (32.2)
|
3 (14.3)
|
0.06
|
|
Levothyroxine
|
7 (8.8)
|
4 (6.8)
|
3 (14.3)
|
0.42
|
|
Diuretic
|
14 (17.5)
|
11 (18.6)
|
3 (14.3)
|
0.48
|
- Significant p-values are shown in bold
- ACE, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; DC, direct current
